Measures of survival benefit in cancer drug development and their limitations.
Etzioni, Ruth
Measures of survival benefit in cancer drug development and their limitations. [electronic resource] - Urologic oncology Mar 2015 - 122-7 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1873-2496
10.1016/j.urolonc.2014.11.002 doi
Antineoplastic Agents--therapeutic use
Chemistry, Pharmaceutical--methods
Disease-Free Survival
Drug Design
Humans
Neoplasms--drug therapy
Outcome Assessment, Health Care
Proportional Hazards Models
Randomized Controlled Trials as Topic
Research Design
Measures of survival benefit in cancer drug development and their limitations. [electronic resource] - Urologic oncology Mar 2015 - 122-7 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1873-2496
10.1016/j.urolonc.2014.11.002 doi
Antineoplastic Agents--therapeutic use
Chemistry, Pharmaceutical--methods
Disease-Free Survival
Drug Design
Humans
Neoplasms--drug therapy
Outcome Assessment, Health Care
Proportional Hazards Models
Randomized Controlled Trials as Topic
Research Design